Complement Pathways in Membranous Nephropathy: Complex and Multifactorial

by Vesna Brglez, Sonia Boyer-Suavet, Barbara Seitz-Polski
Published 2020-05-01

Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy

by Maxime Teisseyre, Sonia Boyer-Suavet, Marion Crémoni, Vesna Brglez, Vincent Esnault, Barbara Seitz-Polski
Published 2021-04-01

Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab

by Sonia Boyer-Suavet, Sonia Boyer-Suavet, Marine Andreani, Maël Lateb, Benjamin Savenkoff, Vesna Brglez, Sylvia Benzaken, Ghislaine Bernard, Patrick H. Nachman, Vincent Esnault, Vincent Esnault, Barbara Seitz-Polski, Barbara Seitz-Polski, Barbara Seitz-Polski
Published 2020-01-01

Personalized Medicine for PLA2R1-Related Membranous Nephropathy: A Multicenter Randomized Control Trial

by Vesna Brglez, Vesna Brglez, Sonia Boyer-Suavet, Sonia Boyer-Suavet, Kévin Zorzi, Kévin Zorzi, Céline Fernandez, Céline Fernandez, Eric Fontas, Vincent Esnault, Vincent Esnault, Barbara Seitz-Polski, Barbara Seitz-Polski, Barbara Seitz-Polski, Barbara Seitz-Polski
Published 2020-08-01

Proteinuria as a Biomarker for COVID-19 Severity

by Hajar Ouahmi, Hajar Ouahmi, Johan Courjon, Johan Courjon, Lucas Morand, Juliette François, Vincent Bruckert, Romain Lombardi, Vincent Esnault, Barbara Seitz-Polski, Barbara Seitz-Polski, Barbara Seitz-Polski, Barbara Seitz-Polski, Elisa Demonchy, Jean Dellamonica, Jean Dellamonica, Sonia Boyer-Suavet, Sonia Boyer-Suavet
Published 2021-03-01

Th17-Immune Response in Patients With Membranous Nephropathy Is Associated With Thrombosis and Relapses

by Marion Cremoni, Marion Cremoni, Vesna Brglez, Vesna Brglez, Sandra Perez, Fabrice Decoupigny, Kévin Zorzi, Kévin Zorzi, Marine Andreani, Alexandre Gérard, Sonia Boyer-Suavet, Sonia Boyer-Suavet, Caroline Ruetsch, Sylvia Benzaken, Vincent Esnault, Barbara Seitz-Polski, Barbara Seitz-Polski, Barbara Seitz-Polski, Barbara Seitz-Polski
Published 2020-11-01

Humoral and Cellular Response of Frontline Health Care Workers Infected by SARS-CoV-2 in Nice, France: A Prospective Single-Center Cohort Study

by Marion Cremoni, Marion Cremoni, Caroline Ruetsch, Kévin Zorzi, Kévin Zorzi, Céline Fernandez, Céline Fernandez, Sonia Boyer-Suavet, Sonia Boyer-Suavet, Sylvia Benzaken, Elisa Demonchy, Jean Dellamonica, Jean Dellamonica, Carole Ichai, Vincent Esnault, Vincent Esnault, Vincent Esnault, Vesna Brglez, Vesna Brglez, Barbara Seitz-Polski, Barbara Seitz-Polski, Barbara Seitz-Polski, Barbara Seitz-Polski
Published 2021-01-01

Anti-PLA2R1 Antibodies Containing Sera Induce In Vitro Cytotoxicity Mediated by Complement Activation

by Maël Lateb, Hajar Ouahmi, Christine Payré, Vesna Brglez, Kevin Zorzi, Guillaume Dolla, Mohamad Zaidan, Sonia Boyer-Suavet, Bertrand Knebelmann, Thomas Crépin, Cécile Courivaud, Noémie Jourde-Chiche, Vincent Esnault, Gérard Lambeau, Barbara Seitz-Polski
Published 2019-01-01

Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients

by Caroline Ruetsch, Caroline Ruetsch, Vesna Brglez, Marion Crémoni, Kévin Zorzi, Céline Fernandez, Sonia Boyer-Suavet, Sylvia Benzaken, Elisa Demonchy, Karine Risso, Johan Courjon, Eric Cua, Carole Ichai, Jean Dellamonica, Jean Dellamonica, Thierry Passeron, Thierry Passeron, Barbara Seitz-Polski, Barbara Seitz-Polski
Published 2021-01-01

Patients with ANCA-associated vasculitis admitted to the intensive care unit with acute vasculitis manifestations: a retrospective and comparative multicentric study

by Julien Demiselle, Johann Auchabie, François Beloncle, Philippe Gatault, Steven Grangé, Damien Du Cheyron, Jean Dellamonica, Sonia Boyer, Dimitri Titeca Beauport, Lise Piquilloud, Julien Letheulle, Christophe Guitton, Nicolas Chudeau, Guillaume Geri, François Fourrier, René Robert, Emmanuel Guérot, Julie Boisramé-Helms, Pierre Galichon, Pierre-François Dequin, Alexandre Lautrette, Pierre-Edouard Bollaert, Ferhat Meziani, Loïc Guillevin, Nicolas Lerolle, Jean-François Augusto
Published 2017-04-01

Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in Adults

by Thomas Barbour, Marie Scully, Gema Ariceta, Spero Cataland, Katherine Garlo, Nils Heyne, Yosu Luque, Jan Menne, Yoshitaka Miyakawa, Sung-Soo Yoon, David Kavanagh, Sunil Babu, Nilufer Broeders, Nicole Lietar, Fiona Brown, Philip Campbell, Josep M. Campistol, Paramit Chowdhury, Theo Kasimatis, Lino Cirami, Leonardo Caroti, Guilia Antognoli, Yahsou Delmas, Vladimir Dobronravov, Anja Gaeckler, Cyril Garrouste, Gregory Greenwood, Siân Griffin, Chiu-Ching Huang, I-Ru Chen, Susan Huang, Jin Seok Kim, Gaetano La Manna, Moglie Le Quintrec, Guillaume Jeantet, Iino Fumie, Eric Rondeau, Hermann Haller, Johan Morelle, Eric Goffin, Anja Muhlfeld, Shashi Nagaraj, Gowthami Arepally, Doyeun Oh, Masayoshi Okumi, Manuel Praga Terente, Francois Provot, Ulf Schönermarck, Michael Fischereder, Natalia Ramos Terrada, Barbara Seitz-Polski, Guillaume Favre, Sonia Boyer-Suavet, Maria Vinogradova, Tatiana Kirsanova, Edwin K.S. Wong
Published 2021-06-01